WallStSmart

Micron Technology Inc (MU)vsNovo Nordisk A/S (NVO)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Novo Nordisk A/S generates 432% more annual revenue ($309.06B vs $58.12B). MU leads profitability with a 41.5% profit margin vs 33.1%. MU appears more attractively valued with a PEG of 0.23. MU earns a higher WallStSmart Score of 83/100 (A-).

MU

Exceptional Buy

83

out of 100

Grade: A-

Growth: 5.3Profit: 10.0Value: 10.0Quality: 8.5
Piotroski: 4/9Altman Z: 3.06

NVO

Buy

55

out of 100

Grade: C

Growth: 4.0Profit: 10.0Value: 4.7Quality: 4.8
Piotroski: 3/9Altman Z: 2.08
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

MUUndervalued (+61.5%)

Margin of Safety

+61.5%

Fair Value

$992.16

Current Price

$382.09

$610.07 discount

UndervaluedFair: $992.16Overvalued
NVOSignificantly Overvalued (-59.4%)

Margin of Safety

-59.4%

Fair Value

$24.21

Current Price

$36.33

$12.12 premium

UndervaluedFair: $24.21Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MU6 strengths · Avg: 10.0/10
Market CapQuality
$446.05B10/10

Mega-cap, among the largest globally

PEG RatioValuation
0.2310/10

Growing faster than its price suggests

Return on EquityProfitability
39.8%10/10

Every $100 of equity generates 40 in profit

Profit MarginProfitability
41.5%10/10

Keeps 42 of every $100 in revenue as profit

Operating MarginProfitability
67.6%10/10

Strong operational efficiency at 67.6%

Altman Z-ScoreHealth
3.0610/10

Safe zone — low bankruptcy risk

NVO5 strengths · Avg: 9.8/10
P/E RatioValuation
10.4x10/10

Attractively priced relative to earnings

Return on EquityProfitability
60.7%10/10

Every $100 of equity generates 61 in profit

Profit MarginProfitability
33.1%10/10

Keeps 33 of every $100 in revenue as profit

Operating MarginProfitability
44.5%10/10

Strong operational efficiency at 44.5%

Market CapQuality
$165.02B9/10

Large-cap with strong market position

Areas to Watch

MU1 concerns · Avg: 4.0/10
Revenue GrowthGrowth
2.0%4/10

2.0% revenue growth

NVO4 concerns · Avg: 2.3/10
Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

PEG RatioValuation
4.882/10

Expensive relative to growth rate

Revenue GrowthGrowth
-7.6%2/10

Revenue declined 7.6%

EPS GrowthGrowth
-4.7%2/10

Earnings declined 4.7%

Comparative Analysis Report

WallStSmart Research

Bull Case : MU

The strongest argument for MU centers on Market Cap, PEG Ratio, Return on Equity. Profitability is solid with margins at 41.5% and operating margin at 67.6%. PEG of 0.23 suggests the stock is reasonably priced for its growth.

Bull Case : NVO

The strongest argument for NVO centers on P/E Ratio, Return on Equity, Profit Margin. Profitability is solid with margins at 33.1% and operating margin at 44.5%.

Bear Case : MU

The primary concerns for MU are Revenue Growth.

Bear Case : NVO

The primary concerns for NVO are Piotroski F-Score, PEG Ratio, Revenue Growth.

Key Dynamics to Monitor

MU profiles as a value stock while NVO is a declining play — different risk/reward profiles.

MU carries more volatility with a beta of 1.54 — expect wider price swings.

MU is growing revenue faster at 2.0% — sustainability is the question.

MU generates stronger free cash flow (6.5B), providing more financial flexibility.

Bottom Line

MU scores higher overall (83/100 vs 55/100), backed by strong 41.5% margins. Both earn "Exceptional Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Micron Technology Inc

TECHNOLOGY · SEMICONDUCTORS · USA

Micron Technology, Inc. is an American producer of computer memory and computer data storage including dynamic random-access memory, flash memory, and USB flash drives. It is headquartered in Boise, Idaho.

Visit Website →

Novo Nordisk A/S

HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA

Novo Nordisk A / S, a healthcare company, is dedicated to the research, development, manufacture and marketing of pharmaceutical products globally. The company is headquartered in Bagsvaerd, Denmark.

Want to dig deeper into these stocks?